Instil Bio Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 13.5% | – | – | – | 18.6% | – | – | – | – | – | – | – | |
| – | -13.5% | – | – | – | -18.6% | – | – | – | – | – | – | – | |
| – | 25.9% | – | – | – | 27.6% | – | – | – | – | – | – | – | |
| – | 141.7% | – | – | – | 260.2% | – | – | – | – | – | – | – | |
| – | 154.1% | – | – | – | 269.2% | – | – | – | – | – | – | – | |
| – | -167.6% | – | – | – | -287.8% | – | – | – | – | – | – | – | |
| – | 25.8% | – | – | – | 65.0% | – | – | – | – | – | – | – | |
| – | -168.5% | – | – | – | -298.4% | – | – | – | – | – | – | – | |
| – | 19.1% | – | – | – | -23.8% | – | – | – | – | – | – | – | |
| – | -168.5% | – | – | – | -298.4% | – | – | – | – | – | – | – | |
| – | -129.2% | – | – | – | -214.9% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.